Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL
Clinical trial NCT04134936 · COMPLETED
Trial details
- NCT number
- NCT04134936
- Sponsor
- MorphoSys AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2021-02-11
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.